Financial statements Biomedipharm
Balance sheet of Biomedipharm
Company age:
Age:
12 y. 6 d.
Share capital:
Share capital:
60 000 PLN
Balance sheet data of BIOMEDIPHARM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 938 633,74 | 1 155 032,02 | 1 183 737,33 | 1 208 842,79 | 1 233 702,06 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 928 433,74 | 1 144 832,02 | 1 183 737,33 | 1 198 642,79 | 1 223 502,06 |
| C. Share capital contributions (basic funds) | 10 200,00 | 10 200,00 | 0,00 | 10 200,00 | 10 200,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 938 633,74 | 1 155 032,02 | 1 183 737,33 | 1 208 842,79 | 1 233 702,06 |
| A. Equity | 925 449,34 | 1 148 840,51 | 1 178 899,15 | 1 194 466,03 | 1 219 504,04 |
| B. Liabilities and provisions for liabilities | 13 184,40 | 6 191,51 | 4 838,18 | 14 376,76 | 14 198,02 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 13 184,40 | 6 191,51 | 4 838,18 | 14 376,76 | 14 198,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.